There is compelling human evidence: mid-life visceral fat correlates with elevated PET markers of both Aβ and tau decades before cognitive symptoms, suggesting neuroinflammation links obesity to preclinical AD progression [111]. The gene discussed is MAPT; the disease is obesity disorder.